Sensei Historical Income Statement
| SNSE Stock | USD 0.60 0.08 15.38% |
Historical analysis of Sensei Biotherapeutics income statement accounts such as Total Revenue of 0.0, Other Operating Expenses of 30.9 M, Research Development of 18 M or Total Operating Expenses of 30.9 M can show how well Sensei Biotherapeutics performed in making a profits. Evaluating Sensei Biotherapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sensei Biotherapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Sensei Biotherapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sensei Biotherapeutics is a good buy for the upcoming year.
Sensei |
About Sensei Income Statement Analysis
Sensei Biotherapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sensei Biotherapeutics shareholders. The income statement also shows Sensei investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Sensei Biotherapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sensei Biotherapeutics. It is also known as Sensei Biotherapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Sensei Biotherapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sensei Biotherapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Sensei Biotherapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sensei Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.At present, Sensei Biotherapeutics' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 1.4 M, whereas Selling General Administrative is forecasted to decline to about 12.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 670K | 219K | 144K | 136.8K | Depreciation And Amortization | 685K | 1.3M | 3.7M | 3.9M |
Sensei Biotherapeutics income statement Correlations
Click cells to compare fundamentals
Sensei Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sensei Biotherapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | (2.3M) | (1.7M) | 130K | 1.6M | 3.5M | 3.7M | |
| Depreciation And Amortization | 72K | 209K | 685K | 1.3M | 3.7M | 3.9M | |
| Interest Expense | 2.3M | 1.7M | 670K | 219K | 144K | 136.8K | |
| Selling General Administrative | 4.1M | 7.5M | 15.8M | 19.8M | 18.7M | 12.9M | |
| Other Operating Expenses | 12.4M | 18.7M | 37.5M | 50.2M | 37.1M | 30.9M | |
| Operating Income | (12.4M) | (19.5M) | (37.5M) | (50.2M) | (37.1M) | (38.9M) | |
| Net Income From Continuing Ops | (16.7M) | (20.1M) | (36.8M) | (48.6M) | (38.9M) | (40.9M) | |
| Ebit | (12.4M) | (18.7M) | (37.5M) | (50.2M) | (37.1M) | (38.9M) | |
| Research Development | 8.4M | 11.2M | 21.7M | 30.4M | 18.3M | 18.0M | |
| Ebitda | (12.4M) | (18.5M) | (36.8M) | (48.8M) | (33.4M) | (35.1M) | |
| Total Operating Expenses | 12.4M | 18.7M | 37.5M | 50.2M | 37.1M | 30.9M | |
| Reconciled Depreciation | 73K | 209K | 685K | 1.3M | 1.4M | 1.4M | |
| Income Before Tax | (16.7M) | (20.1M) | (36.8M) | (48.6M) | (34.1M) | (35.8M) | |
| Total Other Income Expense Net | (4.3M) | (649K) | 688K | 1.6M | 3.0M | 3.1M | |
| Net Income Applicable To Common Shares | (20.5M) | (20.2M) | (36.8M) | (48.6M) | (43.7M) | (45.9M) | |
| Net Income | (19.0M) | (20.6M) | (37.5M) | (48.8M) | (34.1M) | (35.8M) | |
| Income Tax Expense | 2.3M | 529K | 670K | 219K | 100K | 95K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.